BG28055A3 - Method of obtaining of phenylperazine derivatives - Google Patents

Method of obtaining of phenylperazine derivatives

Info

Publication number
BG28055A3
BG28055A3 BG037191A BG3719177A BG28055A3 BG 28055 A3 BG28055 A3 BG 28055A3 BG 037191 A BG037191 A BG 037191A BG 3719177 A BG3719177 A BG 3719177A BG 28055 A3 BG28055 A3 BG 28055A3
Authority
BG
Bulgaria
Prior art keywords
phenylperazine
derivatives
obtaining
proved
formulated
Prior art date
Application number
BG037191A
Other languages
Bulgarian (bg)
Inventor
John Verge
William Jamieson
Original Assignee
Lilly Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Limited filed Critical Lilly Industries Limited
Publication of BG28055A3 publication Critical patent/BG28055A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Метод за получаване на фенилпиперазинови про изводни, охарактеризирани и доказани в описанието с обща формула.... Патентните претенции са формулирани в 7 точки.A method for preparing phenylpiperazine derivatives characterized and proved in the description with a general formula.... The patent claims are formulated in 7 points.

BG037191A 1976-04-23 1977-04-20 Method of obtaining of phenylperazine derivatives BG28055A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
BG28055A3 true BG28055A3 (en) 1980-02-25

Family

ID=10078930

Family Applications (2)

Application Number Title Priority Date Filing Date
BG036062A BG27746A3 (en) 1976-04-23 1977-04-20 Method of obtaining of phenylpiperazine derivatives
BG037191A BG28055A3 (en) 1976-04-23 1977-04-20 Method of obtaining of phenylperazine derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG036062A BG27746A3 (en) 1976-04-23 1977-04-20 Method of obtaining of phenylpiperazine derivatives

Country Status (34)

Country Link
JP (1) JPS52151183A (en)
AR (2) AR222003A1 (en)
AT (1) AT355579B (en)
AU (1) AU514822B2 (en)
BE (1) BE853899A (en)
BG (2) BG27746A3 (en)
CA (1) CA1087617A (en)
CH (2) CH633009A5 (en)
CS (1) CS196360B2 (en)
DD (1) DD129790A5 (en)
DE (1) DE2717415A1 (en)
DK (1) DK176177A (en)
ES (2) ES457988A1 (en)
FI (1) FI63937C (en)
FR (1) FR2348925A1 (en)
GB (1) GB1575904A (en)
GR (1) GR64084B (en)
HU (1) HU176820B (en)
IE (1) IE44730B1 (en)
IL (1) IL51787A (en)
LU (1) LU77170A1 (en)
MX (1) MX4596E (en)
NL (1) NL7704456A (en)
NO (1) NO146710C (en)
NZ (1) NZ183715A (en)
OA (1) OA05643A (en)
PH (1) PH14124A (en)
PL (1) PL117466B1 (en)
PT (1) PT66452B (en)
RO (1) RO72831A (en)
SE (1) SE7704536L (en)
SU (2) SU664564A3 (en)
YU (1) YU104477A (en)
ZA (1) ZA771849B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (en) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen POLYAZO DYES
JPH07157477A (en) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk Production of thiazole derivative
KR970701705A (en) * 1994-03-11 1997-04-12 오노다 마사요시 5-HT₃ receptor agonists, novel thiazole derivatives, and intermediates thereof
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
ES2462240T3 (en) 2006-02-28 2014-05-22 Dart Neuroscience (Cayman) Ltd Therapeutic piperazines as PDE4 inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Also Published As

Publication number Publication date
SU727146A3 (en) 1980-04-05
AT355579B (en) 1980-03-10
PL117466B1 (en) 1981-08-31
IE44730B1 (en) 1982-03-10
BE853899A (en) 1977-10-24
SE7704536L (en) 1977-10-24
DE2717415A1 (en) 1977-11-10
FI63937C (en) 1983-09-12
HU176820B (en) 1981-05-28
LU77170A1 (en) 1979-01-18
JPS52151183A (en) 1977-12-15
NL7704456A (en) 1977-10-25
GR64084B (en) 1980-01-21
ES467948A1 (en) 1978-11-01
GB1575904A (en) 1980-10-01
AR222635A1 (en) 1981-06-15
CH633009A5 (en) 1982-11-15
IE44730L (en) 1977-10-23
ZA771849B (en) 1978-11-29
FI771287A (en) 1977-10-24
RO72831B (en) 1983-07-30
NZ183715A (en) 1980-04-28
RO72831A (en) 1983-08-03
IL51787A (en) 1980-02-29
YU104477A (en) 1983-01-21
ATA285177A (en) 1979-08-15
DD129790A5 (en) 1978-02-08
AU514822B2 (en) 1981-02-26
MX4596E (en) 1982-06-25
PH14124A (en) 1981-02-26
FR2348925A1 (en) 1977-11-18
BG27746A3 (en) 1979-12-12
ES457988A1 (en) 1978-07-16
PT66452B (en) 1979-03-09
PT66452A (en) 1977-05-01
NO771398L (en) 1977-10-25
NO146710B (en) 1982-08-16
FI63937B (en) 1983-05-31
AU2438677A (en) 1978-10-26
IL51787A0 (en) 1977-05-31
CH625802A5 (en) 1981-10-15
DK176177A (en) 1977-10-24
PL197550A1 (en) 1979-05-21
NO146710C (en) 1982-11-24
CS196360B2 (en) 1980-03-31
SU664564A3 (en) 1979-05-25
AR222003A1 (en) 1981-04-15
FR2348925B1 (en) 1980-04-11
OA05643A (en) 1981-04-30
CA1087617A (en) 1980-10-14

Similar Documents

Publication Publication Date Title
BG39467A3 (en) Method for preparing of carboxyalkyl dipeptides
BG28052A4 (en) Method of obtaining of aminoalkyl-heterocycles
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG33286A3 (en) Method for obtaining of 4- hydroxy- 2h- 1, 2- benzothiazin- 3- carboxamid- 1, 1- dioxides
BG36044A3 (en) Method for preparing piperazine derivatives
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
BG29722A3 (en) Method for obtaining of 2, 5- disubstituated pyrimidin- 4- on
BG28699A3 (en) Method of obtaining of alkylendiamine derivatives
BG28068A3 (en) Method of obtaining of 3-chlorcephalosporines
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG28849A3 (en) Method of obtaining of gamapyrons
BG28573A3 (en) METHOD FOR OBTAINING AMINOALKOXYPHENYL DERIVATIVES
BG30778A3 (en) Method for obtaining of eburnamenine derivatives
BG34038A3 (en) A method of obtaining 7- substituted aminoacetamidooxadetiacephalosprorines
BG28987A4 (en) Method of obtaining of n- (1,3,4- thiadizol- 2- il)- benzamid
BG31073A3 (en) Method for obtaining of 1, 5- substituated- 2- pyrolidine
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
BG28055A3 (en) Method of obtaining of phenylperazine derivatives
BG30927A3 (en) Method for obtaining of trans- 4- alpha- phenyl- octahydro- 1h- 2- pyridine
BG28054A3 (en) Method of obtaining of 2-(4-aroylpiperazine-1-il)-4- amino-6,7-dimetoxyhinazoline
BG28845A3 (en) Method of obtaining of n- alkyldiphenylamines
BG35032A3 (en) Method for preparing 1, 1, 2- triphenylpropene derivatives
BG28066A3 (en) Method of obtaining of pyridobenzodiazepinones
BG33436A3 (en) Method for obtaining of 4- dezacetyl- vinblastine- 3- spiro- 5"- oxazolidin- 2", 4"- dion
BG30926A3 (en) Method for obtaining of n- /1- methyl- 2- pyrolidinil- methyl- 2, 3- dimethoxy- 5- methylsulphamoilbenzamid and its derivatives